Patents Assigned to TransTissue Technologies GmbH
  • Publication number: 20080206302
    Abstract: The invention proposes a cell-free graft, comprising (i) a cohesive, structure-forming matrix with open porosity made from a biologically and pharmaceutically acceptable material and (ii) serum. In one particularly preferred embodiment, the matrix additionally contains a gel. By virtue of a second aspect, a method of producing such a cell-free graft is proposed, whereby the matrix and the gel, if one is provided, is placed in contact with the serum. The graft may optionally be dried with serum. Alternatively, the matrix and the gel, if one is provided, are in the dried state before being placed in contact with the serum. By virtue of a third aspect, finally, the invention proposes the use of the cell-free graft for regenerating tissue and in particular for regenerating cartilage and/or bone.
    Type: Application
    Filed: June 29, 2006
    Publication date: August 28, 2008
    Applicant: TRANSTISSUE TECHNOLOGIES GMBH
    Inventors: Michael Sittinger, Eszter Tanczos, Christian Kaps
  • Publication number: 20040028717
    Abstract: Implantable substrate for the healing and/or protection of connective tissue, preferably cartilage, comprising at least one composition for the activation of locally present cells for tissue regeneration and at least one structure for cell invasion in vivo and/or for the formation of cell matrix and/or for the release of constituents of the employed composition.
    Type: Application
    Filed: August 5, 2003
    Publication date: February 12, 2004
    Applicant: TRANSTISSUE TECHNOLOGIES, GmbH
    Inventors: Michael Sittinger, Olaf Schultz, Gerd-Rudiger Burmester
  • Patent number: 6602294
    Abstract: Implantable substrate for the healing and/or protection of connecting tissue, preferably cartilage, comprising at least one composition for the activation of locally present cells for tissue regeneration and at least one structure for cell invasion in vivo and/or for the formation of cell matrix and/or for the release of constituents of the employed composition.
    Type: Grant
    Filed: November 22, 2000
    Date of Patent: August 5, 2003
    Assignee: TransTissue Technologies GmbH
    Inventors: Michael Sittinger, Olaf Schultz, Gerd-Rudiger Burmester